These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 4431876)
1. Proceedings: The "pharmacological bridge": a view from the clinical shores. Sack R; Goodwin FK Psychopharmacol Bull; 1974 Oct; 10(4):52-3. PubMed ID: 4431876 [No Abstract] [Full Text] [Related]
2. Neuropsychopharmacology and the affective disorders (second of three parts). Schildkraut JJ N Engl J Med; 1969 Jul; 281(5):248-55. PubMed ID: 4892998 [No Abstract] [Full Text] [Related]
3. Proceedings: Mechanism of antidepressant efficacy of monoamine oxidase inhibitors: inhibition of monoamine oxidase or of catecholamine reuptake. Snyder SH Psychopharmacol Bull; 1974 Oct; 10(4):16. PubMed ID: 4431859 [No Abstract] [Full Text] [Related]
4. Clinical and animal experiments concerning the function of brain catecholamines. Matussek N Int Pharmacopsychiatry; 1971; 6(3):170-86. PubMed ID: 4950569 [No Abstract] [Full Text] [Related]
5. [Data on the biochemical mechanism of action of antidepressive psychopharmacologic agents]. Baconcini C; Muzio M Sist Nerv; 1971; 23(7):25-35. PubMed ID: 4360412 [No Abstract] [Full Text] [Related]
6. Blood platelets as a model for monoamine-containing neurones. Sneddon JM Prog Neurobiol; 1973; 1(2):151-98. PubMed ID: 4273118 [No Abstract] [Full Text] [Related]
7. Deductive approaches to the catecholamine hypothesis of affective disorders. Wittenborn JR J Nerv Ment Dis; 1974 May; 158(5):320-4. PubMed ID: 4823932 [No Abstract] [Full Text] [Related]
8. 3. Interaction of psychotropic drugs with agents employed in clinical anesthesia. Schmidt KF; Roth RH Clin Anesth; 1967; 3():59-86. PubMed ID: 4296506 [No Abstract] [Full Text] [Related]
10. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors]. Kitaichi Y Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979 [No Abstract] [Full Text] [Related]
11. Theories of biological etiology of affective disorders. Davis JM Int Rev Neurobiol; 1970; 12():145-75. PubMed ID: 4918142 [No Abstract] [Full Text] [Related]
12. Neuropsychobiology of affective disorders. Some methodological considerations. Jain M Neuropsychobiology; 1976; 2(4):247-57. PubMed ID: 796757 [TBL] [Abstract][Full Text] [Related]
13. Proceedings: The effect of psychotropic drugs on the dopa potentiation test in mice. Berendsen H; Leonard BE; Rigter H Br J Pharmacol; 1974 Nov; 52(3):432P-433P. PubMed ID: 4458854 [No Abstract] [Full Text] [Related]
14. [Mechanism of inversion by demethylimipramine of motor depression induced by tetrabenazine]. Lakoza GN Farmakol Toksikol; 1969; 32(4):406-10. PubMed ID: 5307899 [No Abstract] [Full Text] [Related]
15. [Psychotropic drugs in internal medicine. I. Antidepressants]. de la Fuente JR Rev Invest Clin; 1983; 35(3):247-56. PubMed ID: 6415779 [No Abstract] [Full Text] [Related]
16. [Relations between inhibition of cerebral monoamine oxidase in mice and the pyridoxal-5-phosphate-monoamine oxidase inhibitor pharmacological antagonism in the presence of 3,4-dihydroxyphenylalanine]. Lévy J; Michel-Ber E J Physiol (Paris); 1965; 57(4):475-83. PubMed ID: 5848057 [No Abstract] [Full Text] [Related]
17. [General treatments with antidepressants and their importance in general practice]. Frankignoul M Rev Belge Med Dent; 1972 Mar; 27(2):171-83. PubMed ID: 4513488 [No Abstract] [Full Text] [Related]